Casak SJ - Search Results

1

FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements.

Gandhy SU, Casak SJ, Mushti SL, Cheng J, Subramaniam S, Zhao H, Zhao M, Bi Y, Liu G, Fan J, Adeniyi O, Charlab R, Kufrin D, Thompson MD, Jarrell K, Auth D, Lemery SJ, Pazdur R, Kluetz PG, Fashoyin-Aje LA. Gandhy SU, et al. Among authors: casak sj. Clin Cancer Res. 2023 Oct 13;29(20):4027-4031. doi: 10.1158/1078-0432.CCR-23-1042. Clin Cancer Res. 2023. PMID: 37289037 Free PMC article.

2

Retinoblastoma with low risk for extraocular relapse.

Chantada GL, de Dávila MT, Fandiño A, Manzitti J, Raslawski E, Casak S, Schvartzman E. Chantada GL, et al. Ophthalmic Genet. 1999 Sep;20(3):133-40. doi: 10.1076/opge.20.3.133.2277. Ophthalmic Genet. 1999. PMID: 10520234 Clinical Trial.

3

Paediatric oncology in Argentina: medical and ethical issues.

Scopinaro MJ, Casak SJ. Scopinaro MJ, et al. Among authors: casak sj. Lancet Oncol. 2002 Feb;3(2):111-7. doi: 10.1016/s1470-2045(02)00653-8. Lancet Oncol. 2002. PMID: 11902522

4

Children with fever of unknown origin in Argentina: an analysis of 113 cases.

Chantada G, Casak S, Plata JD, Pociecha J, Bologna R. Chantada G, et al. Pediatr Infect Dis J. 1994 Apr;13(4):260-3. doi: 10.1097/00006454-199404000-00003. Pediatr Infect Dis J. 1994. PMID: 8036040

5

Treatment of overt extraocular retinoblastoma.

Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Chantada G, et al. Med Pediatr Oncol. 2003 Mar;40(3):158-61. doi: 10.1002/mpo.10249. Med Pediatr Oncol. 2003. PMID: 12518344

6

Activity of topotecan in retinoblastoma.

Chantada GL, Fandiño AC, Casak SJ, Mato G, Manzitti J, Schvartzman E. Chantada GL, et al. Among authors: casak sj. Ophthalmic Genet. 2004 Mar;25(1):37-43. doi: 10.1076/opge.25.1.37.28996. Ophthalmic Genet. 2004. PMID: 15255113

7

Results of a prospective study for the treatment of retinoblastoma.

Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E. Chantada G, et al. Cancer. 2004 Feb 15;100(4):834-42. doi: 10.1002/cncr.11952. Cancer. 2004. PMID: 14770442 Free article. Clinical Trial.

8

Phase II window of idarubicin in children with extraocular retinoblastoma.

Chantada GL, Fandiño A, Mato G, Casak S. Chantada GL, et al. J Clin Oncol. 1999 Jun;17(6):1847-50. doi: 10.1200/JCO.1999.17.6.1847. J Clin Oncol. 1999. PMID: 10561224 Clinical Trial.

9

Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in Argentina.

Chantada G, Casak S, Alderete D, Zubizarreta P, Gallo G, Muriel FS. Chantada G, et al. Med Pediatr Oncol. 2003 Nov;41(5):488-90. doi: 10.1002/mpo.10288. Med Pediatr Oncol. 2003. PMID: 14515400 No abstract available.

10

U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia.

Casak SJ, Lemery SJ, Shen YL, Rothmann MD, Khandelwal A, Zhao H, Davis G, Jarral V, Keegan P, Pazdur R. Casak SJ, et al. Oncologist. 2011;16(1):97-104. doi: 10.1634/theoncologist.2010-0306. Epub 2011 Jan 6. Oncologist. 2011. PMID: 21212432 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters